Conference Coverage

Migraine is often a deciding factor in pregnancy planning


 

FROM AHS 2020

More education needed

Commenting on the study, Susan Hutchinson, MD, director of the Orange County Migraine and Headache Center, Irvine, California, said that not knowing how pregnancy is going to affect patients’ migraines can be “very scary” for women. In addition, patients often wonder what migraine treatments they can safely take once they do become pregnant, said Dr. Hutchinson, who was not involved in the research.

She noted that advantages of the ARMR data are that they are derived from a multicenter study and that migraine diagnoses were made by a headache specialist. A potential limitation of the study is that the population may not reflect outcomes of the millions of women who have migraine and become pregnant but never see a specialist.

“These findings show that more education is needed,” Dr. Hutchinson said.

Most women, especially those who have migraine without aura, note improvement with migraine during pregnancy, primarily because of the high, steady levels of estradiol, especially in the second and third trimesters, she said. In light of this, neurologists should reassure women that migraine is not a contraindication to pregnancy, she added.

There is also a need for additional research to assess how past experience with migraine and pregnancy influences a woman’s comfort level with additional pregnancies. Studies as to which treatments are safest for acute and preventive treatment of migraine during prepregnancy, pregnancy, and lactation are also needed, Dr. Hutchinson noted.

“If women knew they had treatment options that were evidence-based, they might be much more comfortable contemplating a pregnancy,” she said.

Dr. Ishii and Dr. Hutchinson have disclosed no relevant financial relationships.

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

Persistent posttraumatic headache risk factors confirmed
MDedge Internal Medicine
Daily Recap 6/17
MDedge Internal Medicine
Intranasal DHE shows promise in migraine
MDedge Internal Medicine
CGRPs in real world: Similar efficacy, more AEs
MDedge Internal Medicine
NSAID/triptan combination improves treatment-resistant migraine
MDedge Internal Medicine
Adding CGRP to Botox is safe and effective for migraine prevention
MDedge Internal Medicine
Headache may predict clinical evolution of COVID-19
MDedge Internal Medicine
Daily Recap: Headache as COVID evolution predictor; psoriasis drug treats canker sores
MDedge Internal Medicine
Daily Recap: Healthy lifestyle may stave off dementia; Tentative evidence on marijuana for migraine
MDedge Internal Medicine
Visualization tool aids migraine management
MDedge Internal Medicine